Loading stock data…
Loading stock data…
US$0.33
Get one email when ANEB crosses your level. Checked every 15 minutes during market hours.
▲ +0.33 (82400.00%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
34.4
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.03
Bearish momentumMACD below its signal line (-0.03).
50-day average
0.42
Price belowShort-term trend reference.
200-day average
1.17
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Anebulo Pharmaceuticals Inc. is a biopharmaceutical company focused on developing novel treatments for patients suffering from ailments with few current medical solutions. The company's primary mission is to innovate and advance the development of therapeutic solutions targeting specific unmet medical needs, particularly within the realm of neurology and cannabinoid-related treatments. A noted area of impact for Anebulo Pharmaceuticals is its work on mitigating the effects of cannabinoid overdos…
www.anebulo.com0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2026-06-01)
0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2026-05-01)
0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2026-04-01)
0 strong buy · 0 buy · 3 hold · 1 sell · 2 strong sell (6 analysts, 2026-03-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-06-18 | -0.2 | -0.08 | ✓ Beat |
| 2026-05-27 | 1.28 | 1.47 | ✓ Beat |
| 2026-03-11 | -1.3 | -1.72 | ✗ Miss |
| 2025-11-13 | -0.12 | -0.05 | ✓ Beat |
| 2025-09-29 | -0.05 | -0.05 | ✓ Beat |
| 2025-05-13 | -0.05 | -0.04 | ✓ Beat |
Companies in the same industry, via Finnhub